{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:07:49Z","timestamp":1793052469155,"version":"4.5.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s40265-020-01362-4","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T15:03:55Z","timestamp":1595257435000},"page":"1319-1336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Functional Dyspepsia: Diagnostic and Therapeutic Approaches"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1586-199X","authenticated-orcid":false,"given":"Gregory S.","family":"Sayuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Prakash","family":"Gyawali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"1362_CR1","volume-title":"Disorders of gut\u2013brain interaction","author":"Functional Gastrointestinal Disorders","year":"2016","unstructured":"Functional Gastrointestinal Disorders. Disorders of gut\u2013brain interaction. Raleigh: Rome Foundation; 2016."},{"key":"1362_CR2","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","volume":"150","author":"V Stanghellini","year":"2016","unstructured":"Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016;150:1380\u201392.","journal-title":"Gastroenterology"},{"key":"1362_CR3","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJMra1501505","volume":"373","author":"NJ Talley","year":"2015","unstructured":"Talley NJ, Ford AC. Functional dyspepsia. N Engl J Med. 2015;373:1853\u201363.","journal-title":"N Engl J Med"},{"key":"1362_CR4","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3748\/wjg.v12.i17.2661","volume":"12","author":"S Mahadeva","year":"2006","unstructured":"Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol. 2006;12:2661\u20136.","journal-title":"World J Gastroenterol"},{"key":"1362_CR5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gutjnl-2014-307843","volume":"64","author":"AC Ford","year":"2015","unstructured":"Ford AC, Marwaha A, Sood R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64:1049\u201357.","journal-title":"Gut"},{"key":"1362_CR6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1572-0241.2007.01080.x","volume":"102","author":"AC Ford","year":"2007","unstructured":"Ford AC, Forman D, Bailey AG, et al. Who consults with dyspepsia? Results from a longitudinal 10-year follow-up study. Am J Gastroenterol. 2007;102:957\u201365.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR7","doi-asserted-by":"crossref","first-page":"c6267","DOI":"10.1136\/bmj.c6267","volume":"341","author":"D McBride","year":"2010","unstructured":"McBride D, Hardoon S, Walters K, et al. Explaining variation in referral from primary to secondary care: cohort study. BMJ. 2010;341:c6267.","journal-title":"BMJ"},{"key":"1362_CR8","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/j.1572-0241.2004.40052.x","volume":"99","author":"Y Shaib","year":"2004","unstructured":"Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol. 2004;99:2210\u20136.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR9","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1111\/j.1572-0241.2002.05783.x","volume":"97","author":"NA Koloski","year":"2002","unstructured":"Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol. 2002;97:2290\u20139.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR10","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/j.1572-0241.1999.01427.x","volume":"94","author":"G Tougas","year":"1999","unstructured":"Tougas G, Chen Y, Hwang P, Domestic\/International Gastroenterology Surveillance Study, et al. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Am J Gastroenterol. 1999;94:2845\u201354.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1046\/j.1440-1746.1999.02012.x","volume":"14","author":"K Hirakawa","year":"1999","unstructured":"Hirakawa K, Adachi K, Amano K, et al. Prevalence of non-ulcer dyspepsia in the Japanese population. J Gastroenterol Hepatol. 1999;14:1083\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"1362_CR12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1365-2036.2011.04640.x","volume":"33","author":"P Aro","year":"2011","unstructured":"Aro P, Talley NJ, Agreus L, et al. Functional dyspepsia impairs quality of life in the adult population. Aliment Pharmacol Ther. 2011;33:1215\u201324.","journal-title":"Aliment Pharmacol Ther"},{"key":"1362_CR13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00042737-200406000-00004","volume":"16","author":"P Moayyedi","year":"2004","unstructured":"Moayyedi P, Mason J. Cost-utility and cost-benefit analyses: how did we get here and where are we going? Eur J Gastroenterol Hepatol. 2004;16:527\u201334.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1362_CR14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/apt.12355","volume":"38","author":"BE Lacy","year":"2013","unstructured":"Lacy BE, Weiser KT, Kennedy AT, et al. Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther. 2013;38:170\u20137.","journal-title":"Aliment Pharmacol Ther"},{"key":"1362_CR15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cgh.2010.03.003","volume":"8","author":"RA Brook","year":"2010","unstructured":"Brook RA, Kleinman NL, Choung RS, et al. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010;8:498\u2013503.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1362_CR16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ajg.2012.69","volume":"107","author":"AC Ford","year":"2012","unstructured":"Ford AC, Forman D, Bailey AG, et al. Effect of dyspepsia on survival: a longitudinal 10-year follow-up study. Am J Gastroenterol. 2012;107:912\u201321.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR17","unstructured":"Palsson OS, Whitehead WE, van Tilburg MA, et al. Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians. Gastroenterology. 2016."},{"key":"1362_CR18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/2050640613510904","volume":"1","author":"H Suzuki","year":"2013","unstructured":"Suzuki H, Kusunoki H, Kamiya T, et al. Effect of lansoprazole on the epigastric symptoms of functional dyspepsia (ELF study): a multicentre, prospective, randomized, double-blind, placebo-controlled clinical trial. United Eur Gastroenterol J. 2013;1:445\u201352.","journal-title":"United Eur Gastroenterol J"},{"key":"1362_CR19","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/gutjnl-2014-308114","volume":"64","author":"YJ Fang","year":"2015","unstructured":"Fang YJ, Liou JM, Chen CC, et al. Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria. Gut. 2015;64:1517\u201328.","journal-title":"Gut"},{"key":"1362_CR20","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/j.gastro.2009.12.057","volume":"138","author":"RM Zagari","year":"2010","unstructured":"Zagari RM, Law GR, Fuccio L, et al. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology. 2010;138:1302\u201311.","journal-title":"Gastroenterology"},{"key":"1362_CR21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrgastro.2013.14","volume":"10","author":"J Tack","year":"2013","unstructured":"Tack J, Talley NJ. Functional dyspepsia\u2013symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol. 2013;10:134\u201341.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1262\u201370","key":"1362_CR22","first-page":"e1","volume":"145","author":"AC Ford","year":"2013","unstructured":"Ford AC, Bercik P, Morgan DG, et al. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology. 2013;145(1262\u201370):e1.","journal-title":"Gastroenterology"},{"key":"1362_CR23","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2006.04.029","volume":"131","author":"N Vakil","year":"2006","unstructured":"Vakil N, Moayyedi P, Fennerty MB, et al. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006;131:390\u2013401 (quiz 659\u201360).","journal-title":"Gastroenterology"},{"key":"1362_CR24","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.295.13.1566","volume":"295","author":"P Moayyedi","year":"2006","unstructured":"Moayyedi P, Talley NJ, Fennerty MB, et al. Can the clinical history distinguish between organic and functional dyspepsia? JAMA. 2006;295:1566\u201376.","journal-title":"JAMA"},{"key":"1362_CR25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cgh.2006.11.024","volume":"5","author":"GS Sayuk","year":"2007","unstructured":"Sayuk GS, Elwing JE, Lustman PJ, et al. High somatic symptom burdens and functional gastrointestinal disorders. Clin Gastroenterol Hepatol. 2007;5:556\u201362.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1362_CR26","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1111\/j.1572-0241.2007.01540.x","volume":"102","author":"WE Whitehead","year":"2007","unstructured":"Whitehead WE, Palsson OS, Levy RR, et al. Comorbidity in irritable bowel syndrome. Am J Gastroenterol. 2007;102:2767\u201376.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00004836-200303000-00008","volume":"36","author":"WH Brown","year":"2003","unstructured":"Brown WH, Chey WD, Elta GH. Number of responses on a review of systems questionnaire predicts the diagnosis of functional gastrointestinal disorders. J Clin Gastroenterol. 2003;36:222\u20137.","journal-title":"J Clin Gastroenterol"},{"key":"1362_CR28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/gutjnl-2019-318536","volume":"69","author":"L Wauters","year":"2020","unstructured":"Wauters L, Talley NJ, Walker MM, et al. Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut. 2020;69:591\u2013600.","journal-title":"Gut"},{"key":"1362_CR29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MOG.0000000000000306","volume":"32","author":"NJ Talley","year":"2016","unstructured":"Talley NJ, Walker MM, Holtmann G. Functional dyspepsia. Curr Opin Gastroenterol. 2016;32:467\u201373.","journal-title":"Curr Opin Gastroenterol"},{"key":"1362_CR30","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1053\/j.gastro.2004.09.006","volume":"127","author":"S Delgado-Aros","year":"2004","unstructured":"Delgado-Aros S, Camilleri M, Cremonini F, et al. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology. 2004;127:1685\u201394.","journal-title":"Gastroenterology"},{"key":"1362_CR31","first-page":"478","volume":"58","author":"A Ardila-Hani","year":"2013","unstructured":"Ardila-Hani A, Arabyan M, Waxman A, et al. Severity of dyspeptic symptoms correlates with delayed and early variables of gastric emptying. Dig Dis Sci. 2013;58:478\u201387.","journal-title":"Dig Dis Sci"},{"key":"1362_CR32","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/ajg.2017.264","volume":"112","author":"SY Park","year":"2017","unstructured":"Park SY, Acosta A, Camilleri M, et al. Gastric motor dysfunction in patients with functional gastroduodenal symptoms. Am J Gastroenterol. 2017;112:1689\u201399.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ajg.2016.499","volume":"112","author":"H Vanheel","year":"2017","unstructured":"Vanheel H, Carbone F, Valvekens L, et al. Pathophysiological abnormalities in functional dyspepsia subgroups according to the Rome III criteria. Am J Gastroenterol. 2017;112:132\u201340.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/j.gastro.2004.05.030","volume":"127","author":"J Tack","year":"2004","unstructured":"Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004;127:1239\u201355.","journal-title":"Gastroenterology"},{"key":"1362_CR35","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/gut.2005.078634","volume":"55","author":"NJ Talley","year":"2006","unstructured":"Talley NJ, Locke GR 3rd, Lahr BD, et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut. 2006;55:933\u20139.","journal-title":"Gut"},{"key":"1362_CR36","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/gut.2007.137125","volume":"57","author":"R Bisschops","year":"2008","unstructured":"Bisschops R, Karamanolis G, Arts J, et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut. 2008;57:1495\u2013503.","journal-title":"Gut"},{"key":"1362_CR37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1572-0241.2003.07389.x","volume":"98","author":"G Sarnelli","year":"2003","unstructured":"Sarnelli G, Caenepeel P, Geypens B, et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003;98:783\u20138.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR38","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","volume":"115","author":"J Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115:1346\u201352.","journal-title":"Gastroenterology"},{"key":"1362_CR39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","volume":"132","author":"MD Gershon","year":"2007","unstructured":"Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132:397\u2013414.","journal-title":"Gastroenterology"},{"key":"1362_CR40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cgh.2007.01.007","volume":"5","author":"H Tornblom","year":"2007","unstructured":"Tornblom H, Holmvall P, Svenungsson B, et al. Gastrointestinal symptoms after infectious diarrhea: a 5-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol. 2007;5:461\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1362_CR41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.gastro.2005.04.012","volume":"129","author":"F Mearin","year":"2005","unstructured":"Mearin F, Perez-Oliveras M, Perello A, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: 1-year follow-up cohort study. Gastroenterology. 2005;129:98\u2013104.","journal-title":"Gastroenterology"},{"key":"1362_CR42","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/gut.44.3.400","volume":"44","author":"KA Gwee","year":"1999","unstructured":"Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400\u20136.","journal-title":"Gut"},{"key":"1362_CR43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11894-013-0323-7","volume":"15","author":"L Ohman","year":"2013","unstructured":"Ohman L, Simren M. Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep. 2013;15:323.","journal-title":"Curr Gastroenterol Rep"},{"key":"1362_CR44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/gutjnl-2012-303857","volume":"63","author":"H Vanheel","year":"2014","unstructured":"Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2014;63:262\u201371.","journal-title":"Gut"},{"key":"1362_CR45","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/gut.2006.107714","volume":"56","author":"J Ronkainen","year":"2007","unstructured":"Ronkainen J, Talley NJ, Aro P, et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007;56:615\u201320.","journal-title":"Gut"},{"key":"1362_CR46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jgh.12419","volume":"29","author":"MM Walker","year":"2014","unstructured":"Walker MM, Aggarwal KR, Shim LS, et al. Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an Australian cohort. J Gastroenterol Hepatol. 2014;29:474\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"1362_CR47","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.cgh.2007.05.015","volume":"5","author":"NJ Talley","year":"2007","unstructured":"Talley NJ, Walker MM, Aro P, et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case\u2013control study. Clin Gastroenterol Hepatol. 2007;5:1175\u201383.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1362_CR48","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ajg.2015.158","volume":"110","author":"C Cirillo","year":"2015","unstructured":"Cirillo C, Bessissow T, Desmet AS, et al. Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia. Am J Gastroenterol. 2015;110:1205\u201315.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR49","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ajg.2010.512","volume":"106","author":"T Liebregts","year":"2011","unstructured":"Liebregts T, Adam B, Bredack C, et al. Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. Am J Gastroenterol. 2011;106:1089\u201398.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/j.gastro.2007.11.009","volume":"134","author":"MR Amieva","year":"2008","unstructured":"Amieva MR, El-Omar EM. Host\u2013bacterial interactions in Helicobacter pylori infection. Gastroenterology. 2008;134:306\u201323.","journal-title":"Gastroenterology"},{"key":"1362_CR51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00535-008-2271-9","volume":"44","author":"E Turkkan","year":"2009","unstructured":"Turkkan E, Uslan I, Acarturk G, et al. Does Helicobacter pylori-induced inflammation of gastric mucosa determine the severity of symptoms in functional dyspepsia? J Gastroenterol. 2009;44:66\u201370.","journal-title":"J Gastroenterol"},{"key":"1362_CR52","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.PSY.0000075977.90337.E7","volume":"65","author":"P Henningsen","year":"2003","unstructured":"Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med. 2003;65:528\u201333.","journal-title":"Psychosom Med"},{"key":"1362_CR53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrgastro.2013.10","volume":"10","author":"L Van Oudenhove","year":"2013","unstructured":"Van Oudenhove L, Aziz Q. The role of psychosocial factors and psychiatric disorders in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013;10:158\u201367.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1362_CR54","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2982.2009.01262.x","volume":"21","author":"H Piessevaux","year":"2009","unstructured":"Piessevaux H, De Winter B, Louis E, et al. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil. 2009;21:378\u201388.","journal-title":"Neurogastroenterol Motil"},{"key":"1362_CR55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1572-0241.2000.01735.x","volume":"95","author":"NA Koloski","year":"2000","unstructured":"Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol. 2000;95:67\u201371.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR56","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/ajg.2010.406","volume":"106","author":"S Kindt","year":"2011","unstructured":"Kindt S, Van Oudenhove L, Mispelon L, et al. Longitudinal and cross-sectional factors associated with long-term clinical course in functional dyspepsia: a 5-year follow-up study. Am J Gastroenterol. 2011;106:340\u20138.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.gastro.2009.03.039","volume":"137","author":"P Aro","year":"2009","unstructured":"Aro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009;137:94\u2013100.","journal-title":"Gastroenterology"},{"key":"1362_CR58","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/gutjnl-2011-300474","volume":"61","author":"NA Koloski","year":"2012","unstructured":"Koloski NA, Jones M, Kalantar J, et al. The brain\u2013gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61:1284\u201390.","journal-title":"Gut"},{"key":"1362_CR59","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/nmo.12848","volume":"28","author":"N Kanuri","year":"2016","unstructured":"Kanuri N, Cassell B, Bruce SE, et al. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS). Neurogastroenterol Motil. 2016;28:1508\u201317.","journal-title":"Neurogastroenterol Motil"},{"key":"1362_CR60","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1136\/gutjnl-2012-302634","volume":"62","author":"MP Jones","year":"2013","unstructured":"Jones MP, Coppens E, Vos R, et al. A multidimensional model of psychobiological interactions in functional dyspepsia: a structural equation modelling approach. Gut. 2013;62:1573\u201380.","journal-title":"Gut"},{"key":"1362_CR61","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5056\/jnm18072","volume":"24","author":"M Kano","year":"2018","unstructured":"Kano M, Dupont P, Aziz Q, et al. Understanding neurogastroenterology from neuroimaging perspective: a comprehensive review of functional and structural brain imaging in functional gastrointestinal disorders. J Neurogastroenterol Motil. 2018;24:512\u201327.","journal-title":"J Neurogastroenterol Motil"},{"key":"1362_CR62","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jhn.12506","volume":"31","author":"KR Duncanson","year":"2018","unstructured":"Duncanson KR, Talley NJ, Walker MM, et al. Food and functional dyspepsia: a systematic review. J Hum Nutr Diet. 2018;31:390\u2013407.","journal-title":"J Hum Nutr Diet"},{"key":"1362_CR63","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.gastro.2012.01.020","volume":"142","author":"CC Ferch","year":"2012","unstructured":"Ferch CC, Chey WD. Irritable bowel syndrome and gluten sensitivity without celiac disease: separating the wheat from the chaff. Gastroenterology. 2012;142:664\u20136.","journal-title":"Gastroenterology"},{"issue":"903\u2013911","key":"1362_CR64","first-page":"e3","volume":"144","author":"MI Vazquez-Roque","year":"2013","unstructured":"Vazquez-Roque MI, Camilleri M, Smyrk T, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013;144(903\u2013911):e3.","journal-title":"Gastroenterology"},{"key":"1362_CR65","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4065\/75.9.907","volume":"75","author":"GR Locke 3rd","year":"2000","unstructured":"Locke GR 3rd, Zinsmeister AR, Talley NJ, et al. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000;75:907\u201312.","journal-title":"Mayo Clin Proc"},{"key":"1362_CR66","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1365-2982.2009.01320.x","volume":"21","author":"N Gathaiya","year":"2009","unstructured":"Gathaiya N, Locke GR 3rd, Camilleri M, et al. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009;21:922\u201369.","journal-title":"Neurogastroenterol Motil"},{"key":"1362_CR67","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/apt.12378","volume":"38","author":"VM Kushnir","year":"2013","unstructured":"Kushnir VM, Cassell B, Gyawali CP, et al. Genetic variation in the beta-2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health-related quality of life. Aliment Pharmacol Ther. 2013;38:313\u201323.","journal-title":"Aliment Pharmacol Ther"},{"key":"1362_CR68","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2004.01.006","volume":"126","author":"G Holtmann","year":"2004","unstructured":"Holtmann G, Siffert W, Haag S, et al. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology. 2004;126:971\u20139.","journal-title":"Gastroenterology"},{"key":"1362_CR69","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2982.2008.01102.x","volume":"20","author":"N van Lelyveld","year":"2008","unstructured":"van Lelyveld N, Linde JT, Schipper M, et al. Candidate genotypes associated with functional dyspepsia. Neurogastroenterol Motil. 2008;20:767\u201373.","journal-title":"Neurogastroenterol Motil"},{"key":"1362_CR70","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1572-0241.2006.00481.x","volume":"101","author":"CE Camilleri","year":"2006","unstructured":"Camilleri CE, Carlson PJ, Camilleri M, et al. A study of candidate genotypes associated with dyspepsia in a US community. Am J Gastroenterol. 2006;101:581\u201392.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR71","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2217\/pgs.10.203","volume":"12","author":"S Klenke","year":"2011","unstructured":"Klenke S, Siffert W. SNPs in genes encoding G proteins in pharmacogenetics. Pharmacogenomics. 2011;12:633\u201354.","journal-title":"Pharmacogenomics"},{"key":"1362_CR72","doi-asserted-by":"crossref","first-page":"G1075","DOI":"10.1152\/ajpgi.00537.2011","volume":"302","author":"M Camilleri","year":"2012","unstructured":"Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1075\u201384.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"29\u201335","key":"1362_CR73","first-page":"e4","volume":"22","author":"J Tack","year":"2010","unstructured":"Tack J, Jones MP, Karamanolis G, et al. Symptom pattern and pathophysiological correlates of weight loss in tertiary-referred functional dyspepsia. Neurogastroenterol Motil. 2010;22(29\u201335):e4\u20135.","journal-title":"Neurogastroenterol Motil"},{"key":"1362_CR74","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1046\/j.1365-2036.2000.00862.x","volume":"14","author":"P Bytzer","year":"2000","unstructured":"Bytzer P, Hallas J. Drug-induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions. Aliment Pharmacol Ther. 2000;14:1479\u201384.","journal-title":"Aliment Pharmacol Ther"},{"key":"1362_CR75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00042737-199801000-00006","volume":"10","author":"J Hallas","year":"1998","unstructured":"Hallas J, Bytzer P. Screening for drug related dyspepsia: an analysis of prescription symmetry. Eur J Gastroenterol Hepatol. 1998;10:27\u201332.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1362_CR76","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2005.00225.x","volume":"100","author":"NJ Talley","year":"2005","unstructured":"Talley NJ, Vakil N, Practice Parameters Committee of the American College of G. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005;100:2324\u201337.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"1362_CR77","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1083-4389.2004.00254.x","volume":"9","author":"A Makristathis","year":"2004","unstructured":"Makristathis A, Hirschl AM, Lehours P, et al. Diagnosis of Helicobacter pylori infection. Helicobacter. 2004;9(Suppl 1):7\u201314.","journal-title":"Helicobacter"},{"key":"1362_CR78","doi-asserted-by":"crossref","unstructured":"Best LM, Takwoingi Y, Siddique S, et al. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev 2018;3:CD012080.","DOI":"10.1002\/14651858.CD012080.pub2"},{"key":"1362_CR79","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ajg.2017.154","volume":"112","author":"P Moayyedi","year":"2017","unstructured":"Moayyedi P, Lacy BE, Andrews CN, et al. ACG and CAG Clinical Guideline: management of dyspepsia. Am J Gastroenterol. 2017;112:988\u20131013.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR80","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5662\/wjm.v4.i3.189","volume":"4","author":"L Petrarca","year":"2014","unstructured":"Petrarca L, Nenna R, Mastrogiorgio G, et al. Dyspepsia and celiac disease: prevalence, diagnostic tools and therapy. World J Methodol. 2014;4:189\u201396.","journal-title":"World J Methodol"},{"key":"1362_CR81","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/MOG.0b013e32833ece1e","volume":"26","author":"J Tack","year":"2010","unstructured":"Tack J, Janssen P. Gastroduodenal motility. Curr Opin Gastroenterol. 2010;26:647\u201355.","journal-title":"Curr Opin Gastroenterol"},{"key":"1362_CR82","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.cgh.2017.05.013","volume":"15","author":"NB Vakil","year":"2017","unstructured":"Vakil NB, Howden CW, Moayyedi P, et al. White Paper AGA: Functional Dyspepsia. Clin Gastroenterol Hepatol. 2017;15:1191\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1362_CR83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ajg.2017.265","volume":"113","author":"F Taylor","year":"2018","unstructured":"Taylor F, Higgins S, Carson RT, et al. Development of a symptom-focused patient-reported outcome measure for functional dyspepsia: the functional dyspepsia symptom diary (functional dyspepsia SD). Am J Gastroenterol. 2018;113:39\u201348.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR84","first-page":"3242","volume":"17","author":"L Lan","year":"2011","unstructured":"Lan L, Yu J, Chen YL, et al. Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia. World J Gastroenterol. 2011;17:3242\u20137.","journal-title":"World J Gastroenterol"},{"key":"1362_CR85","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3748\/wjg.v12.i17.2677","volume":"12","author":"C O\u2019Morain","year":"2006","unstructured":"O\u2019Morain C. Role of Helicobacter pylori in functional dyspepsia. World J Gastroenterol. 2006;12:2677\u201380.","journal-title":"World J Gastroenterol"},{"key":"1362_CR86","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","volume":"112","author":"WD Chey","year":"2017","unstructured":"Chey WD, Leontiadis GI, Howden CW, et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112:212\u201339.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","volume":"153","author":"MF Vaezi","year":"2017","unstructured":"Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology. 2017;153:35\u201348.","journal-title":"Gastroenterology"},{"key":"1362_CR88","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrgastro.2011.272","volume":"9","author":"P Moayyedi","year":"2012","unstructured":"Moayyedi P, Leontiadis GI. The risks of PPI therapy. Nat Rev Gastroenterol Hepatol. 2012;9:132\u20139.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1362_CR89","doi-asserted-by":"crossref","unstructured":"Pinto-Sanchez MI, Yuan Y, Bercik P, et al. Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst Rev 2017;3:CD011194.","DOI":"10.1002\/14651858.CD011194.pub3"},{"key":"1362_CR90","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/17474124.2019.1543586","volume":"13","author":"K Van Den Houte","year":"2019","unstructured":"Van Den Houte K, Carbone F, Tack J. Postprandial distress syndrome: stratification and management. Expert Rev Gastroenterol Hepatol. 2019;13:37\u201346.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1362_CR91","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000357854","volume":"32","author":"F Carbone","year":"2014","unstructured":"Carbone F, Tack J. Gastroduodenal mechanisms underlying functional gastric disorders. Dig Dis. 2014;32:222\u20139.","journal-title":"Dig Dis"},{"key":"1362_CR92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coph.2018.08.015","volume":"43","author":"J Tack","year":"2018","unstructured":"Tack J, Camilleri M. New developments in the treatment of gastroparesis and functional dyspepsia. Curr Opin Pharmacol. 2018;43:111\u20137.","journal-title":"Curr Opin Pharmacol"},{"key":"1362_CR93","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41395-018-0258-6","volume":"114","author":"R Pittayanon","year":"2019","unstructured":"Pittayanon R, Yuan Y, Bollegala NP, et al. Prokinetics for functional dyspepsia: a systematic review and meta-analysis of randomized control trials. Am J Gastroenterol. 2019;114:233\u201343.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR94","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2036.2012.05011.x","volume":"35","author":"J Tack","year":"2012","unstructured":"Tack J, Camilleri M, Chang L, et al. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012;35:745\u201367.","journal-title":"Aliment Pharmacol Ther"},{"key":"1362_CR95","doi-asserted-by":"crossref","unstructured":"Al-Saffar A, Lennernas H, Hellstrom PM. Gastroparesis, metoclopramide, and tardive dyskinesia: risk revisited. Neurogastroenterol Motil. 2019;e13617.","DOI":"10.1111\/nmo.13617"},{"key":"1362_CR96","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1752-1947-8-34","volume":"8","author":"S Nennstiel","year":"2014","unstructured":"Nennstiel S, Bajbouj M, Schmid RM, et al. Prucalopride reduces the number of reflux episodes and improves subjective symptoms in gastroesophageal reflux disease: a case series. J Med Case Rep. 2014;8:34.","journal-title":"J Med Case Rep"},{"key":"1362_CR97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40261-015-0360-0","volume":"36","author":"N Leelakanok","year":"2016","unstructured":"Leelakanok N, Holcombe A, Schweizer ML. Domperidone and risk of ventricular arrhythmia and cardiac death: a systematic review and meta-analysis. Clin Drug Investig. 2016;36:97\u2013107.","journal-title":"Clin Drug Investig"},{"key":"1362_CR98","first-page":"224","volume":"69","author":"AD Morris","year":"2016","unstructured":"Morris AD, Chen J, Lau E, et al. Domperidone-associated QT interval prolongation in non-oncologic pediatric patients: a review of the literature. Can J Hosp Pharm. 2016;69:224\u201330.","journal-title":"Can J Hosp Pharm"},{"key":"1362_CR99","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1046\/j.1365-2036.2001.01103.x","volume":"15","author":"L Degen","year":"2001","unstructured":"Degen L, Matzinger D, Merz M, et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther. 2001;15:1745\u201351.","journal-title":"Aliment Pharmacol Ther"},{"key":"1362_CR100","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10620-009-1049-0","volume":"55","author":"WD Chey","year":"2010","unstructured":"Chey WD, Howden CW, Tack J, et al. Long-term tegaserod treatment for dysmotility-like functional dyspepsia: results of two identical 1-year cohort studies. Dig Dis Sci. 2010;55:684\u201397.","journal-title":"Dig Dis Sci"},{"key":"1362_CR101","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1572-0241.2007.01654.x","volume":"103","author":"N Vakil","year":"2008","unstructured":"Vakil N, Laine L, Talley NJ, et al. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol. 2008;103:1906\u201319.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR102","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1074248409360357","volume":"15","author":"J Loughlin","year":"2010","unstructured":"Loughlin J, Quinn S, Rivero E, et al. Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study. J Cardiovasc Pharmacol Ther. 2010;15:151\u20137.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"1362_CR103","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cgh.2012.06.036","volume":"10","author":"J Tack","year":"2012","unstructured":"Tack J, Janssen P, Masaoka T, et al. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol. 2012;10:1239\u201345.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1362_CR104","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/egh.12.34","volume":"6","author":"E Altan","year":"2012","unstructured":"Altan E, Masaoka T, Farre R, et al. Acotiamide, a novel gastroprokinetic for the treatment of patients with functional dyspepsia: postprandial distress syndrome. Expert Rev Gastroenterol Hepatol. 2012;6:533\u201344.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1362_CR105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000332404","volume":"84","author":"K Matsueda","year":"2011","unstructured":"Matsueda K, Hongo M, Ushijima S, et al. A long-term study of acotiamide in patients with functional dyspepsia: results from an open-label phase III trial in Japan on efficacy, safety and pattern of administration. Digestion. 2011;84:261\u20138.","journal-title":"Digestion"},{"issue":"65\u201376","key":"1362_CR106","first-page":"e11","volume":"154","author":"PJ Pasricha","year":"2018","unstructured":"Pasricha PJ, Yates KP, Sarosiek I, et al. Aprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disorders. Gastroenterology. 2018;154(65\u201376):e11.","journal-title":"Gastroenterology"},{"key":"1362_CR107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/146642400112100113","volume":"121","author":"LI Spirling","year":"2001","unstructured":"Spirling LI, Daniels IR. Botanical perspectives on health peppermint: more than just an after-dinner mint. J R Soc Promot Health. 2001;121:62\u20133.","journal-title":"J R Soc Promot Health"},{"key":"1362_CR108","first-page":"7654947","volume":"2019","author":"J Li","year":"2019","unstructured":"Li J, Lv L, Zhang J, et al. A combination of peppermint oil and caraway oil for the treatment of functional dyspepsia: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2019;2019:7654947.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"Suppl 5","key":"1362_CR109","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.phymed.2006.03.022","volume":"13","author":"W Rosch","year":"2006","unstructured":"Rosch W, Liebregts T, Gundermann KJ, et al. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5. Phytomedicine. 2006;13(Suppl 5):114\u201321.","journal-title":"Phytomedicine"},{"key":"1362_CR110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-2002-32130","volume":"40","author":"W Rosch","year":"2002","unstructured":"Rosch W, Vinson B, Sassin I. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. Z Gastroenterol. 2002;40:401\u20138.","journal-title":"Z Gastroenterol"},{"key":"1362_CR111","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1572-0241.2007.01142.x","volume":"102","author":"AN Pilichiewicz","year":"2007","unstructured":"Pilichiewicz AN, Horowitz M, Russo A, et al. Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol. 2007;102:1276\u201383.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR112","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1572-0241.2006.01183.x","volume":"102","author":"U von Arnim","year":"2007","unstructured":"von Arnim U, Peitz U, Vinson B, et al. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol. 2007;102:1268\u201375.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR113","doi-asserted-by":"crossref","first-page":"A642","DOI":"10.1016\/S0016-5085(01)83189-9","volume":"120","author":"RE Clouse","year":"2001","unstructured":"Clouse RE, Prakash C, Anderson RJ. Antidepressants for functional gastrointestinal symptoms and syndromes: a meta-analysis. Gastroenterology. 2001;120:A642.","journal-title":"Gastroenterology."},{"key":"1362_CR114","doi-asserted-by":"crossref","first-page":"e0157798","DOI":"10.1371\/journal.pone.0157798","volume":"11","author":"Y Lu","year":"2016","unstructured":"Lu Y, Chen M, Huang Z, et al. Antidepressants in the treatment of functional dyspepsia: a systematic review and meta-analysis. PLoS One. 2016;11:e0157798.","journal-title":"PLoS One"},{"key":"1362_CR115","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/gut.52.4.598","volume":"52","author":"RE Clouse","year":"2003","unstructured":"Clouse RE. Antidepressants for irritable bowel syndrome. Gut. 2003;52:598\u20139.","journal-title":"Gut"},{"key":"1362_CR116","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/gut.2004.047423","volume":"54","author":"V Morgan","year":"2005","unstructured":"Morgan V, Pickens D, Gautam S, et al. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut. 2005;54:601\u20137.","journal-title":"Gut"},{"key":"1362_CR117","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","volume":"151","author":"PK Gillman","year":"2007","unstructured":"Gillman PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol. 2007;151:737\u201348.","journal-title":"Br J Pharmacol"},{"key":"1362_CR118","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gutjnl-2015-310721","volume":"66","author":"AC Ford","year":"2017","unstructured":"Ford AC, Luthra P, Tack J, et al. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut. 2017;66:411\u201320.","journal-title":"Gut"},{"issue":"340\u20139","key":"1362_CR119","first-page":"e2","volume":"149","author":"NJ Talley","year":"2015","unstructured":"Talley NJ, Locke GR, Saito YA, et al. Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study. Gastroenterology. 2015;149(340\u20139):e2.","journal-title":"Gastroenterology"},{"key":"1362_CR120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2003.01469.x","volume":"17","author":"J Tack","year":"2003","unstructured":"Tack J, Broekaert D, Coulie B, et al. Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther. 2003;17:603\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"1362_CR121","doi-asserted-by":"crossref","first-page":"G130","DOI":"10.1152\/ajpgi.00266.2002","volume":"284","author":"HJ Chial","year":"2003","unstructured":"Chial HJ, Camilleri M, Burton D, et al. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol. 2003;284:G130\u20137.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1362_CR122","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","volume":"7","author":"SA Anttila","year":"2001","unstructured":"Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7:249\u201364.","journal-title":"CNS Drug Rev"},{"key":"1362_CR123","doi-asserted-by":"crossref","unstructured":"Carbone F, Vanuytsel T, Tack J. The effect of mirtazapine on gastric accommodation, gastric sensitivity to distention, and nutrient tolerance in healthy subjects. Neurogastroenterol Motil 2017;29.","DOI":"10.1111\/nmo.13146"},{"issue":"385\u2013392","key":"1362_CR124","first-page":"e4","volume":"14","author":"J Tack","year":"2016","unstructured":"Tack J, Ly HG, Carbone F, et al. Efficacy of mirtazapine in patients with functional dyspepsia and weight loss. Clin Gastroenterol Hepatol. 2016;14(385\u2013392):e4.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1362_CR125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00535-012-0726-5","volume":"48","author":"M Grover","year":"2013","unstructured":"Grover M, Camilleri M. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases. J Gastroenterol. 2013;48:177\u201381.","journal-title":"J Gastroenterol"},{"key":"1362_CR126","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2147\/NDT.S35922","volume":"9","author":"M Preve","year":"2013","unstructured":"Preve M, Nisita C, Bellini M, et al. Duloxetine in panic disorder with somatic gastric pain. Neuropsychiatr Dis Treat. 2013;9:1811\u20133.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1362_CR127","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cgh.2008.02.051","volume":"6","author":"LA van Kerkhoven","year":"2008","unstructured":"van Kerkhoven LA, Laheij RJ, Aparicio N, et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2008;6:746\u201352 (quiz 718).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1362_CR128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s007020050151","volume":"106","author":"J Maj","year":"1999","unstructured":"Maj J, Rogoz Z. Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems. J Neural Transm (Vienna). 1999;106:197\u2013211.","journal-title":"J Neural Transm (Vienna)"},{"key":"1362_CR129","doi-asserted-by":"crossref","first-page":"e000144","DOI":"10.1136\/bmjgast-2017-000144","volume":"4","author":"M Igarashi","year":"2017","unstructured":"Igarashi M, Nakae H, Matsuoka T, et al. Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia. BMJ Open Gastroenterol. 2017;4:e000144.","journal-title":"BMJ Open Gastroenterol"},{"key":"1362_CR130","doi-asserted-by":"crossref","first-page":"e19107","DOI":"10.1097\/MD.0000000000019107","volume":"99","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wu HM, Wang X, et al. Efficacy of prebiotics and probiotics for functional dyspepsia: a systematic review and meta-analysis. Medicine (Baltimore). 2020;99:e19107.","journal-title":"Medicine (Baltimore)"},{"key":"1362_CR131","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","volume":"364","author":"M Pimentel","year":"2011","unstructured":"Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22\u201332.","journal-title":"N Engl J Med"},{"key":"1362_CR132","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/apt.13945","volume":"45","author":"VP Tan","year":"2017","unstructured":"Tan VP, Liu KS, Lam FY, et al. Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia. Aliment Pharmacol Ther. 2017;45:767\u201376.","journal-title":"Aliment Pharmacol Ther"},{"key":"1362_CR133","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.37071","volume":"123","author":"EL Calvert","year":"2002","unstructured":"Calvert EL, Houghton LA, Cooper P, et al. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology. 2002;123:1778\u201385.","journal-title":"Gastroenterology"},{"key":"1362_CR134","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.psy.0000249734.99065.6f","volume":"69","author":"C Cheng","year":"2007","unstructured":"Cheng C, Yang FC, Jun S, et al. Flexible coping psychotherapy for functional dyspeptic patients: a randomized, controlled trial. Psychosom Med. 2007;69:81\u20138.","journal-title":"Psychosom Med"},{"key":"1362_CR135","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jpsychores.2015.03.003","volume":"78","author":"M Orive","year":"2015","unstructured":"Orive M, Barrio I, Orive VM, et al. A randomized controlled trial of a 10\u00a0week group psychotherapeutic treatment added to standard medical treatment in patients with functional dyspepsia. J Psychosom Res. 2015;78:563\u20138.","journal-title":"J Psychosom Res"},{"key":"1362_CR136","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1365-2036.2007.03277.x","volume":"25","author":"S Haag","year":"2007","unstructured":"Haag S, Senf W, Tagay S, et al. Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther. 2007;25:973\u201386.","journal-title":"Aliment Pharmacol Ther"},{"key":"1362_CR137","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/gast.2000.16493","volume":"119","author":"J Hamilton","year":"2000","unstructured":"Hamilton J, Guthrie E, Creed F, et al. A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology. 2000;119:661\u20139.","journal-title":"Gastroenterology"},{"key":"1362_CR138","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0022-3999(94)90026-4","volume":"38","author":"TT Haug","year":"1994","unstructured":"Haug TT, Wilhelmsen I, Svebak S, et al. Psychotherapy in functional dyspepsia. J Psychosom Res. 1994;38:735\u201344.","journal-title":"J Psychosom Res"},{"key":"1362_CR139","first-page":"43","volume":"10","author":"M Faramarzi","year":"2015","unstructured":"Faramarzi M, Azadfallah P, Book HE, et al. The effect of psychotherapy in improving physical and psychiatric symptoms in patients with functional dyspepsia. Iran J Psychiatry. 2015;10:43\u20139.","journal-title":"Iran J Psychiatry"},{"key":"1362_CR140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ajg.2011.340","volume":"107","author":"P Lindfors","year":"2012","unstructured":"Lindfors P, Unge P, Arvidsson P, et al. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Am J Gastroenterol. 2012;107:276\u201385.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR141","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cgh.2012.10.031","volume":"11","author":"OS Palsson","year":"2013","unstructured":"Palsson OS, Whitehead WE. Psychological treatments in functional gastrointestinal disorders: a primer for the gastroenterologist. Clin Gastroenterol Hepatol. 2013;11:208\u201316 (quiz e22\u20133).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1362_CR142","doi-asserted-by":"crossref","first-page":"e704","DOI":"10.1097\/MJT.0000000000001033","volume":"26","author":"SL Popa","year":"2019","unstructured":"Popa SL, Chiarioni G, David L, et al. The efficacy of hypnotherapy in the treatment of functional dyspepsia. Am J Ther. 2019;26:e704\u201313.","journal-title":"Am J Ther"},{"key":"1362_CR143","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/00365521.2012.658858","volume":"47","author":"P Lindfors","year":"2012","unstructured":"Lindfors P, Unge P, Nyhlin H, et al. Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome. Scand J Gastroenterol. 2012;47:414\u201320.","journal-title":"Scand J Gastroenterol"},{"key":"1362_CR144","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cgh.2008.03.004","volume":"6","author":"JM Lackner","year":"2008","unstructured":"Lackner JM, Jaccard J, Krasner SS, et al. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility. Clin Gastroenterol Hepatol. 2008;6:899\u2013906.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1362_CR145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1471-2458-11-215","volume":"11","author":"E Andersson","year":"2011","unstructured":"Andersson E, Ljotsson B, Smit F, et al. Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial. BMC Public Health. 2011;11:215.","journal-title":"BMC Public Health"},{"key":"1362_CR146","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/nmo.12022","volume":"25","author":"P Lindfors","year":"2013","unstructured":"Lindfors P, Ljotsson B, Bjornsson E, et al. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome. Neurogastroenterol Motil. 2013;25:169\u201386.","journal-title":"Neurogastroenterol Motil"},{"key":"1362_CR147","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ajg.2011.139","volume":"106","author":"B Ljotsson","year":"2011","unstructured":"Ljotsson B, Hedman E, Andersson E, et al. Internet-delivered exposure-based treatment vs stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol. 2011;106:1481\u201391.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR148","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ctim.2015.07.007","volume":"23","author":"KN Kim","year":"2015","unstructured":"Kim KN, Chung SY, Cho SH. Efficacy of acupuncture treatment for functional dyspepsia: a systematic review and meta-analysis. Complement Ther Med. 2015;23:759\u201366.","journal-title":"Complement Ther Med"},{"key":"1362_CR149","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1089\/acm.2014.0400","volume":"22","author":"W Zhou","year":"2016","unstructured":"Zhou W, Su J, Zhang H. Efficacy and safety of acupuncture for the treatment of functional dyspepsia: meta-analysis. J Altern Complement Med. 2016;22:380\u20139.","journal-title":"J Altern Complement Med"},{"key":"1362_CR150","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ajg.2012.53","volume":"107","author":"F Zeng","year":"2012","unstructured":"Zeng F, Qin W, Ma T, et al. Influence of acupuncture treatment on cerebral activity in functional dyspepsia patients and its relationship with efficacy. Am J Gastroenterol. 2012;107:1236\u201347.","journal-title":"Am J Gastroenterol"},{"key":"1362_CR151","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/gut.2007.147728","volume":"57","author":"S Mahadeva","year":"2008","unstructured":"Mahadeva S, Chia YC, Vinothini A, et al. Cost-effectiveness of and satisfaction with a Helicobacter pylori \u201ctest and treat\u201d strategy compared with prompt endoscopy in young Asians with dyspepsia. Gut. 2008;57:1214\u201320.","journal-title":"Gut"},{"key":"1362_CR152","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006:CD002096.","DOI":"10.1002\/14651858.CD002096.pub4"},{"key":"1362_CR153","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/archinternmed.2011.533","volume":"171","author":"LE Mazzoleni","year":"2011","unstructured":"Mazzoleni LE, Sander GB, Francesconi CF, et al. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch Intern Med. 2011;171:1929\u201336.","journal-title":"Arch Intern Med"},{"key":"1362_CR154","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.318.7187.833","volume":"318","author":"NJ Talley","year":"1999","unstructured":"Talley NJ, Janssens J, Lauritsen K, et al. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12\u00a0months\u2019 follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ. 1999;318:833\u20137.","journal-title":"BMJ"},{"issue":"Suppl 3","key":"1362_CR155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1440-1746.2011.06629.x","volume":"26","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Nishizawa T, Hibi T. Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? J Gastroenterol Hepatol. 2011;26(Suppl 3):42\u20135.","journal-title":"J Gastroenterol Hepatol"},{"key":"1362_CR156","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","volume":"64","author":"K Sugano","year":"2015","unstructured":"Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353\u201367.","journal-title":"Gut"},{"key":"1362_CR157","unstructured":"Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. In: (NICE) NIfHaCE, ed. Volume CG 184, September 2014 (Revised October 2019)."},{"key":"1362_CR158","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrgastro.2014.53","volume":"11","author":"JE Kurlander","year":"2014","unstructured":"Kurlander JE, Drossman DA. Diagnosis and treatment of narcotic bowel syndrome. Nat Rev Gastroenterol Hepatol. 2014;11:410\u20138.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1362_CR159","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/apt.14503","volume":"47","author":"GS Sayuk","year":"2018","unstructured":"Sayuk GS, Kanuri N, Gyawali CP, et al. Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health Administration. Aliment Pharmacol Ther. 2018;47:784\u201391.","journal-title":"Aliment Pharmacol Ther"},{"key":"1362_CR160","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ajg.2012.142","volume":"107","author":"DA Drossman","year":"2012","unstructured":"Drossman DA, Morris CB, Edwards H, et al. Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome. Am J Gastroenterol. 2012;107:1426\u201340.","journal-title":"Am J Gastroenterol"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-020-01362-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-020-01362-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-020-01362-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T23:26:41Z","timestamp":1626737201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-020-01362-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":160,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1362"],"URL":"https:\/\/doi.org\/10.1007\/s40265-020-01362-4","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]},"assertion":[{"value":"20 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was received for the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Gregory Sayuk has given scientific advice to Allergan, Ironwood, Abbvie, and Salix. He has served on the Speaker Bureau for Allergan, Ironwood, Salix, and Alnylam.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}